Glob Bioenergi (ALGBE) - Total Assets
Based on the latest financial reports, Glob Bioenergi (ALGBE) holds total assets worth €9.65 Million EUR (≈ $11.28 Million USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Glob Bioenergi (ALGBE) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Glob Bioenergi - Total Assets Trend (2008–2024)
This chart illustrates how Glob Bioenergi's total assets have evolved over time, based on quarterly financial data. See Glob Bioenergi shareholders equity for net asset value and shareholders' equity analysis.
Glob Bioenergi - Asset Composition Analysis
Current Asset Composition (December 2024)
Glob Bioenergi's total assets of €9.65 Million consist of 90.6% current assets and 9.4% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €170.53K | 48.6% |
| Accounts Receivable | €1.71 Million | 17.7% |
| Inventory | €401.90K | 4.2% |
| Property, Plant & Equipment | €486.32K | 5.0% |
| Intangible Assets | €69.23K | 0.7% |
| Goodwill | €-1.19 Million | -12.4% |
Asset Composition Trend (2008–2024)
This chart illustrates how Glob Bioenergi's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Glob Bioenergi.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Glob Bioenergi's current assets represent 90.6% of total assets in 2024, a decrease from 94.1% in 2008.
- Cash Position: Cash and equivalents constituted 48.6% of total assets in 2024, up from 7.6% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up -12.0% of total assets, a decrease from 1.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 17.7% of total assets.
Glob Bioenergi Competitors by Total Assets
Key competitors of Glob Bioenergi based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Zhejiang Satellite Petrochemical Co Ltd
SHE:002648
|
China | CN¥74.65 Billion |
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP
|
Germany | €15.49 Billion |
|
Lily Group Co Ltd
SHG:603823
|
China | CN¥3.49 Billion |
|
MeiHua Holdings Group Co Ltd
SHG:600873
|
China | CN¥25.99 Billion |
|
Shandong Dongyue Organosilicon Mat
SHE:300821
|
China | CN¥6.27 Billion |
|
Zibo Qixiang Tengda Chemical Co Ltd
SHE:002408
|
China | CN¥25.55 Billion |
|
Jiangsu Ruitai New Energy Materials Co. Ltd.
SHE:301238
|
China | CN¥9.46 Billion |
|
Yibin Tianyuan Group Co Ltd
SHE:002386
|
China | CN¥19.28 Billion |
Glob Bioenergi - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.47 | 3.35 | 5.66 |
| Quick Ratio | 1.40 | 3.23 | 5.49 |
| Cash Ratio | 0.03 | 0.04 | 0.00 |
| Working Capital | €2.79 Million | €10.56 Million | €17.40 Million |
Glob Bioenergi - Advanced Valuation Insights
This section examines the relationship between Glob Bioenergi's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.20 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -47.1% |
| Total Assets | €9.65 Million |
| Market Capitalization | $335.38K USD |
Valuation Analysis
Below Book Valuation: The market values Glob Bioenergi's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Glob Bioenergi's assets decreased by 47.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Glob Bioenergi (2008–2024)
The table below shows the annual total assets of Glob Bioenergi from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €9.65 Million ≈ $11.28 Million |
-47.13% |
| 2023-12-31 | €18.25 Million ≈ $21.34 Million |
-15.40% |
| 2022-12-31 | €21.58 Million ≈ $25.23 Million |
-32.12% |
| 2021-12-31 | €31.79 Million ≈ $37.16 Million |
+23.21% |
| 2020-12-31 | €25.80 Million ≈ $30.16 Million |
-7.69% |
| 2019-12-31 | €27.95 Million ≈ $32.67 Million |
+9.87% |
| 2018-12-31 | €25.44 Million ≈ $29.74 Million |
-17.55% |
| 2017-12-31 | €30.85 Million ≈ $36.07 Million |
+20.81% |
| 2016-12-31 | €25.54 Million ≈ $29.86 Million |
+14.98% |
| 2015-12-31 | €22.21 Million ≈ $25.97 Million |
-7.52% |
| 2014-12-31 | €24.02 Million ≈ $28.08 Million |
-9.29% |
| 2013-12-31 | €26.48 Million ≈ $30.95 Million |
+183.82% |
| 2012-12-31 | €9.33 Million ≈ $10.91 Million |
+60.86% |
| 2011-12-31 | €5.80 Million ≈ $6.78 Million |
-15.18% |
| 2010-12-31 | €6.84 Million ≈ $7.99 Million |
+1662.11% |
| 2009-12-31 | €388.00K ≈ $453.61K |
-26.07% |
| 2008-12-31 | €524.80K ≈ $613.55K |
-- |
About Glob Bioenergi
Global Bioenergies SA is in the process of liquidation. Previously, the company was engaged in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company was incorporated in 2008 and is headquartered in Évry, France.